Resultados de la búsqueda 231-240 of 23174 for Two-phase
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Randomized Phase II/III Trial of Adjuvant ... A Study To Compare Two Surgical Procedures In Women With BRCA1 Mutations To Assess Reduced Risk Of Ovarian Cancer.
... phase 2 dose (RP2D) for future study after treatment with SONALA-001 in combination with MRgFUS in subjects with progressive or rGBM. Renal Intervention For ...
A Phase 1/2 Study Of ... Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations.
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...
This phase I trial studies the best dose and side ... [1, 2] The solid tumor stroma acts as an ... This Phase 3 study is designed to evaluate the ...
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla.
Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. ... two lines of therapy as measured by objective response ...
Patients will be randomized 1:1 into the two arms. Patients randomized to ... Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients.
Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?